Jian Lin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma (NCT07686744) | Jian Lin | 2026-09-01 |
Track Jian Lin automatically
Every clearance here is in the API, with alerts when new ones post.